| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2080145 | Drug Discovery Today | 2012 | 4 Pages |
Abstract
In this article we discuss the pros and cons of medicinal chemists undertaking three-dimensional (3D) computer-aided drug design (CADD) activities for themselves, from the viewpoint of both medicinal chemists and computational chemists. We describe how best this can be implemented, the potential benefits that can be obtained and the pitfalls that are often encountered.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Timothy J. Ritchie, Iain M. McLay,